Randomized, Double-Blind, Placebo-Controlled Phase III Trial of Apatinib in Patients With Chemotherapy-Refractory Advanced or Metastatic Adenocarcinoma of the Stomach or Gastroesophageal JunctionJin Li, Hao Yu, Shukui Qin et al.|Journal of Clinical Oncology|2016Cited by 1k
B7-H3 expression associates with tumor invasion and patient's poor survival in human esophageal cancer.Lujun Chen, Jingting Jiang, Jun Chen et al.|PubMed|2015Cited by 62
The regimen of gemcitabine and cisplatin combined with radio frequency hyperthermia for advanced non-small cell lung cancer: A phase II studyHua Shen, Yongqian Shu, Xiaodong Li et al.|International Journal of Hyperthermia|2010Cited by 36
Multicenter randomized double-blind controlled phase III study of hhpg-19K as prophylactic therapy in patients with advanced non-small cell lung cancer (NSCLC) receiving myelosuppressive chemotherapy.Caicun Zhou, Jielai Xia, Changping Wu et al.|Journal of Clinical Oncology|2014Cited by 0